Literature DB >> 7774633

Toxoplasma gondii-specific CD4+ T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion.

I Prigione1, P Facchetti, F Ghiotto, P Tasso, V Pistoia.   

Abstract

Human Toxoplasma gondii (Tg)-specific T cell clones were raised by infecting peripheral blood mononuclear cells (MNC) from two healthy, latently infected individuals with Tg trophozoites. All of the clones had a CD4+ immunophenotype and produced simultaneously interleukin (IL)-2, interferon (IFN)-gamma, IL-4 and IL-5 upon mitogen or antigen stimulation. Tg-specific T cell clones were classified as T helper of type 0 (Th0) since most of them released roughly comparable amounts of IFN-gamma and IL-4. In some clones, a trend to an increased production of IFN-gamma following antigen-specific as compared to non-specific stimulation was observed. The Th0 phenotype was also expressed by T cell clones that had been raised from bulk cultures performed in the presence of IL-4 or IFN-gamma. All of the Tg-specific T cell clones were cytolytic in a non-specific assay which involves the triggering of the CD3-T cell receptor (TcR) complex. Some clones specifically lysed an autologous lymphoblastoid cell line (LCL) that had been infected with Tg trophozoites. Finally, most of the Tg-specific T cell clones produced IL-10, irrespective of whether they had been raised from bulk cultures incubated in the presence or absence of IL-4 or IFN-gamma. Taken together, these findings suggest that Tg-specific Th0 helper cell clones from healthy, latently infected individuals, beside activating toxoplasmacidal mechanisms through IFN-gamma release, might limit the magnitude of the immune response of the parasite by killing Tg-infected antigen-presenting cells and by releasing IL-10.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774633     DOI: 10.1002/eji.1830250525

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Proband and Familial Autoimmune Diseases Are Associated With Proband Diagnosis of Autism Spectrum Disorders.

Authors:  Marisa N Spann; Laura Timonen-Soivio; Auli Suominen; Keely Cheslack-Postava; Ian W McKeague; Andre Sourander; Alan S Brown
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-02-16       Impact factor: 8.829

2.  Prenatal toxoplasmosis antibody and childhood autism.

Authors:  Marisa N Spann; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Alan S Brown
Journal:  Autism Res       Date:  2016-11-22       Impact factor: 5.216

3.  Detection of a novel 40,000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages.

Authors:  G Reichmann; S Stachelhaus; R Meisel; M N Mévélec; J F Dubremetz; H Dlugonska; H G Fischer
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

4.  A switch towards Th2 during serological rebound in children with congenital toxoplasmosis.

Authors:  S Kahi; G J Cozon; J M Pinon; T Greenland; M Wallon; M Al Kurdi; J Ferrandiz; F Peyron
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

5.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Maternal toxoplasmosis and the risk of childhood autism: serological and molecular small-scale studies.

Authors:  Jamila S Al Malki; Nahed Ahmed Hussien; Fuad Al Malki
Journal:  BMC Pediatr       Date:  2021-03-17       Impact factor: 2.125

7.  Spontaneous cytokine production in children according to biological characteristics and environmental exposures.

Authors:  Camila Alexandrina Figueiredo; Neuza Maria Alcântara-Neves; Rafael Veiga; Leila D Amorim; Vitor Dattoli; Lívia Ribeiro Mendonça; Samuel Junqueira; Bernd Genser; Mariese Santos; Lain Carlos Pontes de Carvalho; Philip J Cooper; Laura Rodrigues; Maurício L Barreto
Journal:  Environ Health Perspect       Date:  2009-01-09       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.